Transforming Growth Factor Beta Receptor II Dominant Negative Modulation (TGFBR2 DN)

Transforming growth factor beta receptor II (TGFBR2) is a transmembrane serine/threonine kinase that forms part of the TGF-beta receptor complex. It plays a central role in mediating cellular responses to TGF-beta ligands, which regulate cell proliferation, differentiation, apoptosis, and immune function. The "dominant negative" modulation refers to engineered or naturally occurring mutant forms of TGFBR2 that interfere with normal signaling—typically by lacking kinase activity or being unable to propagate downstream signals—thus acting as inhibitors of the pathway. This approach is being explored therapeutically for its potential in cancer immunotherapy due to its ability to enhance cytotoxic lymphocyte responses against tumors while reducing immunosuppressive regulatory mechanisms within the tumor microenvironment.

Other names

Dominant negative TGFBR2TGF-beta receptor II dominant negativednTGFBR2

Dominant negative inhibition of TGF-beta receptor signaling, leading to enhanced cytotoxic T lymphocyte activity and reduced regulatory T cell function.